Skip to main content

Commit To Buy Zynerba Pharmaceuticals At $10, Earn 27.7% Annualized Using Options

Investors eyeing a purchase of Zynerba Pharmaceuticals Inc (ZYNE) stock, but cautious about paying the going market price of $11.73/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the August put at the $10 strike, which has a bid at the time of this writing of $1.60..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.